Literature DB >> 25981945

Effects of ketamine on psychomotor, sensory and cognitive functions relevant for driving ability.

R Giorgetti1, D Marcotulli2, A Tagliabracci2, F Schifano3.   

Abstract

Ketamine is a dissociative anesthetic. The misuse of ketamine as a recreational drug has increased over the last decade, especially in rave parties or clubs. Short-term ketamine pilot protocols have been undertaken for treatment-resistant depressive clients. In this study, we review and comment on the evidence relating to the potential of ketamine as a causative/contributory factor in traffic accidents. To determine the causal role of ketamine in traffic accidents, a literature search on the psychomotor, cognitive, visual and perceptual functions related to safe driving was conducted. Furthermore, to interpret related data better, an overview of ketamine and its congeners' clinical pharmacology issues, recreational psychoactive effects, and identification in biological specimens is also provided.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive deterioration; Drug misuse; Drugs and driving; Ketamine

Mesh:

Substances:

Year:  2015        PMID: 25981945     DOI: 10.1016/j.forsciint.2015.04.024

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  11 in total

1.  A methoxydiphenidine-impaired driver.

Authors:  Nicole Stachel; Andrea Jacobsen-Bauer; Gisela Skopp
Journal:  Int J Legal Med       Date:  2015-10-19       Impact factor: 2.686

2.  Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.

Authors:  Frederick S Barrett; Theresa M Carbonaro; Ethan Hurwitz; Matthew W Johnson; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2018-07-30       Impact factor: 4.530

3.  Driving while under the influence of hallucinogens: Prevalence, correlates, and risk profiles.

Authors:  Christopher P Salas-Wright; Manuel Cano; James Hodges; Sehun Oh; Audrey Hang Hai; Michael G Vaughn
Journal:  Drug Alcohol Depend       Date:  2021-09-23       Impact factor: 4.492

Review 4.  Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability.

Authors:  Michael D Kritzer; Chi-Un Pae; Prakash S Masand
Journal:  Expert Opin Drug Saf       Date:  2022-04-29       Impact factor: 4.011

Review 5.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

6.  The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.

Authors:  Aurora J A E van de Loo; Adriana C Bervoets; Loes Mooren; Noor H Bouwmeester; Johan Garssen; Rob Zuiker; Guido van Amerongen; Joop van Gerven; Jaskaran Singh; Peter Van der Ark; Maggie Fedgchin; Randall Morrison; Ewa Wajs; Joris C Verster
Journal:  Psychopharmacology (Berl)       Date:  2017-07-28       Impact factor: 4.530

Review 7.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

8.  Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder.

Authors:  Margaret T Davis; Nicole DellaGiogia; Paul Maruff; Robert H Pietrzak; Irina Esterlis
Journal:  Transl Psychiatry       Date:  2021-04-08       Impact factor: 6.222

9.  Demographic and Lifestyle Characteristics, but Not Apolipoprotein E Genotype, Are Associated with Intelligence among Young Chinese College Students.

Authors:  Xiao-Fen Chen; Zichen Wei; Tingting Wang; Zhen-Lian Zhang; Yiwei Wang; Michael G Heckman; Nancy N Diehl; Yun-Wu Zhang; Huaxi Xu; Guojun Bu
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

10.  A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance.

Authors:  Shengfang Su; Gary Kay; Thomas Hochadel; Jonathan Rojo; J Christopher Stein; Ramesh Boinpally; Antonia Periclou
Journal:  Clin Transl Sci       Date:  2021-11-07       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.